CPHI: China Pharma Holdings, Inc. Company Profile & Statistics

China Pharma Holdings, Inc. Profile

About

CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.

Info & Links

CEO

Zhilin Li

Headquarters

Second Floor, No. 17, Jinpan Road
Haikou, F4 570216, CHINA

Auditor

Enrome LLP

Share holders

137

Employees

231

China Pharma Holdings, Inc. Statistics

Valuation Measures

Market Capitalization²

6.39M

Enterprise Value

7.79M

Enterprise Value/EBITDA(ttm)

-4.11

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.47

Price to Book(mrq)

0.93

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

-20.46%

Operating Margin(ttm)

-83.17%

Profit Margin(ttm)

-82.56%

Return on Equity(ttm)

-51.62%

Return on Invested Capital(ttm)

-43.63%

Return on Assets(ttm)

-25.76%

Income Statement

Revenue(ttm)

4.40M

Revenue Per Share(ttm)

1.35

Gross Profit(ttm)

-903.30K

EBITDA(ttm)³

-1.90M

Net Income Available to Common(ttm)

-3.66M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

0.95

52-Week Change

-10.38%

S&P 500 52-Week Change

16.93%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

3.26M

Dividend Yield

0.00%

Float⁴

2.70M

% Held by Insiders

17.32%

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

625.00K

Total Cash Per Share(mrq)

0.19

Total Debt(mrq)

2.02M

Total Debt/Equity(mrq)

31.24%

Current Ratio(mrq)

0.51%

Quick Ratio(mrq)

0.17%

Book Value Per Share(mrq)

1.98

Cash Flow

Operating Cash Flow Per Share(ytd)

0.07

Free Cash Flow(ytd)

175.00K

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

CPHI

China Pharma Holdings, Inc.